Bayer faces mounting lawsuits

Article Abstract:

Bayer AG is seeing a higher number of lawsuits being filed against it in connection to its Baycol cholesterol drug. Concerns have been raised about the company's ability to survive the potentially huge liabilities that could come about from the suits.

Bayer AG, Actions and defenses, Litigation, Lawsuit/litigation, BAYZY, Baycol (Medication), License lawsuit, Actions and defences

---

Biogen to pay Schering in fight

Article Abstract:

Biogen Corp. has reached a deal with Schering AG in which it will pay the latter an additional $55 million (51.1 million euros) for a patent dispute. The dispute involves both firms' rival multiple sclerosis drugs.

United States, Patents & copyrights, Care and treatment, Intellectual property, Multiple sclerosis, Biogen Inc., BGEN, Schering AG

---

German prosecutor opens probe into EM.TV

Article Abstract:

Munich prosecutors began investigating EM.TV & Merchandising AG after shareholder groups claimed that the media firm issued false information about its finances.

Television Broadcasting, Television broadcasting stations, Television broadcasting industry, Investigations, EM.TV and Merchandising AG

Similar abstracts:

• Abstracts: UBS net falls 57%, but inflows surge. UBS is expected to post fall in net profit. UBS net rose 73% in third quarter, beating estimates
• Abstracts: Buffing up Birks. Birks thinks outside the closet. Birks thinks inside the box
• Abstracts: Gov't comes down on Carlsberg ad. Molson Canadian toasts Canadiana. The education of Michael Downey
• Abstracts: Pinning down the young folk. Buy on the fly. The quickie getaway
• Abstracts: Merger mania comes to Central Europe. SABMiller is close to deal to buy Colombian brewer. Carlsberg to divest of several assets for Orkla merger

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.